Dementia is a term used to describe memory loss, impaired reasoning, difficulties communicating and other mental impairments ...

Looking for your next TV obsession? Channel 4 is about to deliver it in the form of its creepy new mystery thriller Careless.

[BASEL] Novartis forecast a profit decline for 2026, as some of the Swiss drugmaker’s top sellers – such as the heart ...

Tr1X, a clinical-stage autoimmune and inflammatory disease company developing Type 1 regulatory T (Tr1) cell therapies, today announced the first clinical data from its ongoing Phase 1 study of TRX103 ...

A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

Teva Canada and Novartis Canada are collaborating to ensure continued access to Mayzent for people with active SPMS in Canada ...

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New research from Sweden links higher levels of per- and polyfluoroalkyl ...

Our team at the UK Dementia Research Institute’s Biomarker Factory at UCL are part of the global effort working to develop ...

A judge says U.S. immigration agents in Oregon must stop arresting people without warrants unless they are likely to escape.

Azenta, Inc. today reported financial results for the first quarter ended December 31, 2025.The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, ...

Detailed price information for Kyverna Therapeutics Inc (KYTX-Q) from The Globe and Mail including charting and trades.